Note: Ingredients listed on restricted chemical lists
EC/CAS
231-906-6/7778-50-9
Name of the chemical
Potassium dichromate
Concentration
=1-<2,5
General Information
Version
8.1
Revision date
2024-11-09
Product name
Potassium dichromate solution c(K2Cr2O7) = 1/24 mol/l (0.25 N) Titripur
REACH No
This
1.2.1 Relevant identified uses
Reagent for analysis
Emergency telephone
+(44)-870-8200418, +(353)-19014670, 001-803-017-9114
Icons in SDS
Company Information
company name
Merck KGaA
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H334, H340, H350, H360FD, H373, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Skin irritation, (Category 2) H315: Causes skin irritation. Eye irritation, (Category 2) H319: Causes serious eye irritation. Respiratory sensitization, H334: May cause allergy or asthma (Category 1) symptoms or breathing difficulties if inhaled. Skin sensitization, (Category 1) H317: May cause an allergic skin reaction. Germ cell mutagenicity, H340: May cause genetic defects. (Category 1B) Carcinogenicity, (Category 1B) H350: May cause cancer. Reproductive toxicity, (Category H360FD: May damage fertility. May 1B) damage the unborn child. Specific target organ toxicity - H373: May cause damage to organs repeated exposure, (Category 2), through prolonged or repeated exposure if Cardio-vascular system inhaled. Long-term (chronic) aquatic H412: Harmful to aquatic life with long hazard, (Category 3) lasting effects.
2.2 Label elements
Labelling
Signal word
Danger Danger
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H340 May cause genetic defects. H350 May cause cancer. H360FD May damage fertility. May damage the unborn child. H373 May cause damage to organs (Cardio-vascular system) through prolonged or repeated exposure if inhaled. H412 Harmful to aquatic life with long lasting effects. Restricted to professional users. Reduced Labeling (<= 125 ml) H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction. H340 May cause genetic defects. H350 May cause cancer. H412 Harmful to aquatic life with long lasting effects. H360FD May damage fertility. May damage the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.